<DOC>
	<DOC>NCT00784719</DOC>
	<brief_summary>A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.</brief_summary>
	<brief_title>A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Symptoms of dry eye for at least 6 months. Signs of moderate to severe dry eye Women who are nursing or pregnant Participation in other studies within 30 days of screening visit Ocular disorders that may confound interpretation of study results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Dry eye</keyword>
</DOC>